A carregar...

Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer’s Transgenic Mice Lessen during Disease Progression

The β-secretase enzyme BACE1, which initiates the cleavage of amyloid precursor protein (APP) into the amyloid-β (Aβ) peptide, is a prime therapeutic target for Alzheimer’s disease (AD). However, recent investigations using genetic animal models raise concern that therapeutic BACE1 inhibition may en...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Alzheimer Res
Main Authors: Devi, Latha, Tang, Jordan, Ohno, Masuo
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4414026/
https://ncbi.nlm.nih.gov/pubmed/25523425
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!